Bacteriophage T7, a virus that preys on E. coli, becomes a more effective killer after spending time aboard the International ...

Bacteriophages, nature's microscopic and most abundant biological entities, have been extensively studied for their potential ...

Megan Baldridge and her co-workers will use their Global Grant for Gut Health (GGGH) to examine which human proteins interact with bacteriophage viruses in the gut, and how this might trigger ...

As bacteria become increasingly (and worryingly) resistant to antibiotics, scientists are recruiting bacteriophages—a bacteria’s sworn evolutionary enemy—to fight against these troublesome “superbugs.

As antibiotic-resistant infections increasingly threaten public health, interest in bacteriophages as therapeutics has seen a resurgence. However, the field remains largely limited to naturally ...

Antimicrobial resistance—when bacteria and fungi defend themselves against the drugs designed to kill them—is an urgent threat to global public health, according to the Centers for Disease Control and ...

Bacteriophages are viruses that can kill bacteria through highly specific interactions. While this property can be beneficial in selected applications, bacteriophages represent a serious threat to ...

Scientists can now design virus-based bacteria killers from scratch, potentially reshaping the fight against antibiotic resistance. Bacteriophages have been used therapeutically to treat infectious ...

Antibiotics have long been the go-to treatment for various infections. Still, almost as soon as the treatment was discovered in 1945, widespread use led to the rise of a new problem: antibiotic ...

Viruses attack nearly every living organism on Earth. To do so, they rely on highly specialized proteins that recognize and bind to receptors on the surface of target cells, a molecular arms race that ...

Locus Biosciences Awarded $3.3 Million from NIH to Support Clinical Trial of AI-Designed Bacteriophage Therapy for Pneumonia caused by Antibiotic Resistant Bacteria Locus Biosciences today announced a ...